| Literature DB >> 23300797 |
Gilberto Sousa Alves1, Laurence O'Dwyer, Alina Jurcoane, Viola Oertel-Knöchel, Christian Knöchel, David Prvulovic, Felipe Sudo, Carlos Eduardo Alves, Letice Valente, Denise Moreira, Fabian Fußer, Fabian Fuβer, Tarik Karakaya, Johannes Pantel, Eliasz Engelhardt, Jerson Laks.
Abstract
Alzheimeŕs disease (AD) represents the most prevalent neurodegenerative disorder that causes cognitive decline in old age. In its early stages, AD is associated with microstructural abnormalities in white matter (WM). In the current study, multiple indices of diffusion tensor imaging (DTI) and brain volumetric measurements were employed to comprehensively investigate the landscape of AD pathology. The sample comprised 58 individuals including cognitively normal subjects (controls), amnestic mild cognitive impairment (MCI) and AD patients. Relative to controls, both MCI and AD subjects showed widespread changes of anisotropic fraction (FA) in the corpus callosum, cingulate and uncinate fasciculus. Mean diffusivity and radial changes were also observed in AD patients in comparison with controls. After controlling for the gray matter atrophy the number of regions of significantly lower FA in AD patients relative to controls was decreased; nonetheless, unique areas of microstructural damage remained, e.g., the corpus callosum and uncinate fasciculus. Despite sample size limitations, the current results suggest that a combination of secondary and primary degeneration occurrs in MCI and AD, although the secondary degeneration appears to have a more critical role during the stages of disease involving dementia.Entities:
Mesh:
Year: 2012 PMID: 23300797 PMCID: PMC3534120 DOI: 10.1371/journal.pone.0052859
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical characteristics of the sample groups.1
| CN (n = 17) | MCI (n = 18) | AD (n = 23) | F/χ | |
|
| 14/3 | 9/9 | 10/13 | 6.530 (0.038) |
|
| 71.18±8.06 | 72.83±6.51 | 76.35±6.73 | 2.823 (0.068) |
|
| 10.41±3.52 | 7.11±4.75 | 9.04±5.17 | 2.272 (0.113) |
|
| 0.00±0.00 | 0.39±0.27 | 1.39±0.66 | 53.741 (<0.001) |
|
| 28.35±1.41 | 26.22±3.42 | 20.35±5.91 | 19.308 (<0.001) |
|
| 0.06±0.24 | 1.44±1.46 | 16.83±7.18 | 84.285 (<0.001) |
|
| 13.88±1.05 | 12.06±2.63 | 8.91±3.90 | 14.754 (<0.001) |
|
| 16.24±4.18 | 13.61±4.53 | 9.82±5.10 | 9.374 (<0.001) |
|
| 21.58±2.69 | 16.94±4.57 | 8.72±5.51 | 40.64 (<0.001) |
|
| 11.24±0.90 | 10.11±1.23 | 9.23±1.95 | 8.796 (<0.001) |
Values are displayed as mean ± SD. M = male, F = female. CDR = Clinical Dementia Rating Scale; MMSE = Mini-mental state examination; CAMCOG = Cambridge Cognitive Examination; CN = Cognitively Normal; MCI = Mild Cognitive Impairment; AD = Alzheimer Dementia;
Bonferroni correction;
Composite score with memory items from CAMCOG and MMSE.
Post hoc analysis with Bonferroni correction:
AD vs CN, P<0.01; AD vs MCI, P<0.01; MCI vs CN, P<0.05;
AD vs CN, P<0.01; AD vs MCI, P<0.01; MCI vs CN, P>0.05;
AD vs CN, P<0.01; AD vs MCI, P<0.05; MCI vs CN, P>0.05;
AD vs CN, P<0.01; AD vs MCI and MCI vs CN, P>0.05.
Brain volumetric comparisons with normalized values.
| CN (n = 17) | MCI (n = 18) | AD (n = 23) | F (P) | |
|
| 655,531±157,698 | 567,854±176,335 | 473,575±171,231 | 5.725 (0.006)* |
|
| 742,875±100,817 | 685,995±207,756 | 779,344±203,226 | 1.344 (0.269) |
|
| 3,886±0,534 | 3,903±0,703 | 3,191±0,865 | 6.426 (0.003)† |
|
| 3,957±0,679 | 3,770±0,563 | 3,109±0,704 | 9.180 (0.000)§ |
|
| 1398,406±198,649 | 1253,850±156,211 | 1252,919±308,455 | 2.216 (0.119) |
|
| 8.200±6.661 | 8.338±4.394 | 10.919±6.694 | 1.300 (0.281) |
WMH = white matter hyperintensities; CN = Cognitively Normal; MCI = Mild Cognitive Impairment; AD = Alzheimer Dementia; volume expressed in mm3 (1) and ml (2).
Post hoc analysis: *AD vs CN, P = 0.004; † AD vs CN, P = 0.013; † AD vs MCI, P = 0.009; § AD vs CN, P = 0.001; §AD vs MCI, P = 0.012; values are displayed as mean ± standard deviations;
Figure 1Distribution of diffusion tensor MRI indices for the global WM ROI in controls, MCI and AD patients.
Multivariate Analysis reported significant differences between groups for FA (F = 4.649, df = 2, P<0.05), axial diffusivity (F = 5.610, df = 2, P<0.05), MD (F = 6.821, df = 2, P<0.005) and radial diffusivity (F = 7.131, df = 2, P<0.005). *P<0.05, **P<0.01, corrected for multiple comparisons using Bonferroni correction.
Figure 2TBSS maps showing voxelwise comparisons between patients and controls.
The mean FA skeleton (green voxels) projected on the FMRIB template brain. Low FA in AD patients in is shown in dark red (A); low FA in MCI is shown in yellow-red (B); high MD in AD is depicted in blue (C) and high radial diffusivity in orange.
Figure 3Overlapping WM regions between controls and AD for specific DTI indices.
Areas of overlap between low FA (red) and high MD (blue) suggest gross tissue loss and are depicted in the upper panels (A) and (B); FA decreases (red) overlapping with radial diffusivity increases (orange) are shown in the lower panels (C) and (D) and suggest areas of myelin damage.
Figure 4FA results adjusting for GM atrophy differences between groups.
Upper panels (A) and (B): TBSS maps show low FA in the AD group in comparison to controls. The figures results from two GLM models designed for group comparisons. The model 1 included age and gender as covariates and is represented by the sum of blue and red voxels. The model 2 added as covariate the GM volume to the model 1 and is identified as red voxels. Red areas representing the remaining voxels after controlling for the GM atrophy can be seen mostly in the left hemisphere. They include WM tracts such as the left anterior corona radiate and the left and right corpus callosum (A) and the right cingulate gyrus (B). For a detailed description see the results section. Lower panels (C) and (D): TBSS maps show low FA in the MCI group relatively to controls. Note that statistical significant areas resemble those from the AD-control contrast seen before in the model 2 (upper panel).
Correlation1 between FA values and Brain Volumetric variables from the voxelwise ROIs.
| ROI (FA values) | Volume | |||
| White Matter | Gray Matter | |||
| MCI | AD | MCI | AD | |
| Anterior thalamic radiation (L) | 0.566** | −0.001 | −0.628** | 0.288 |
| Anterior thalamic radiation (R) | 0.726** | 0.002 | −0.525* | 0.256 |
| Cingulate Gyrus (L) | 0.653** | 0.239 | −0.448 | 0.207 |
| Cingulate Gyrus (R) | 0.635** | 0.119 | −0.439 | 0.153 |
| Cingulum hippocampus (R) | −0.422 | NA | NA | NA |
| Cingulum hippocampus (L) | 0.170 | NA | 0.546* | NA |
| Forceps Minor | 0.734** | 0.142 | −0.567* | 0.283 |
| IFOF(L) | 0.506* | −0.053 | −0.483* | 0.328 |
| IFOF(R) | 0.724** | −0.011 | −0.596** | 0.213 |
| ILF(L) | −0.134 | NA | 0.116 | NA |
| SLF (L) | 0.124 | 0.022 | −0.272 | 0.250 |
| SLF(R) | 0.505* | −0.054 | −0.300 | 0.047 |
| SLFtemporal part (L) | 0.419 | −0.111 | −0.541* | 0.281 |
| SLFtemporal part (R) | 0.478* | −0.034 | −0.237 | 0.033 |
| Uncinate Fasciculus (L) | 0.509* | −0.074 | −0.505* | 0.321 |
| Uncinate Fasciculus (R) | 0.692** | −0.003 | −0.696** | 0.218 |
Note - Values are Pearson Correlation coefficients; *statistical significance at level <0.05 (*) and <0.01 (**); CN = Cognitively Normal; MCI = Mild Cognitive Impairment; AD = Alzheimer Dementia; NA = not assessed because WM tract was not statistical significant; R = right; L = left; IFOF = inferior fronto-occipito fasciculus; ILF = Inferior longitudinal fasciculus; SLF = superior longitudinal fasciculus.
FA values extracted from voxelwise region of interests (ROIs); for MCI the ROI from the contrast MCI versus controls (controlled for age and gender); for AD the ROI from the contrast AD versus control (controlled for gender, age and gray matter).
Volume in mm3.